[Combined treatment of Helicobacter pylori infection--7-day or 14-day treatment?].
Muszyński
J
J
Kliniki Gastroenterologii i Chorób Przemiany Materii IChW, Warszawie.
Czyzyk
A
A
Biernacka
D
D
Pachecka
J
J
Stepka
M
M
Zalewski
L
L
D000328:Adult; D000368:Aged; D001729:Bismuth; D002214:Capsules; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D004415:Dyspepsia / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D005756:Gastritis / Q000150:complications / Q000188:drug therapy*; D005765:Gastrointestinal Agents / Q000008:administration & dosage*; D016481:Helicobacter Infections / Q000150:complications / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D008297:Male; D008795:Metronidazole / Q000008:administration & dosage*; D008875:Middle Aged; D009942:Organometallic Compounds / Q000008:administration & dosage*; D012459:Salicylates / Q000008:administration & dosage*; D013752:Tetracycline / Q000008:administration & dosage*; D013997:Time Factors
D002214:Capsules; D004338:Drug Combinations; D005765:Gastrointestinal Agents; D009942:Organometallic Compounds; D012459:Salicylates; D008795:Metronidazole; C015715:bismuth subsalicylate; D013752:Tetracycline; D001729:Bismuth
Skojarzone leczenie zakazenia Helicobacter pylori--terapia 7 czy 14-dniowa?